SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-21-027010
Filing Date
2021-11-17
Accepted
2021-11-17 20:19:42
Documents
1
Period of Report
2021-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 3417
  Complete submission text file 0001437749-21-027010.txt   4742
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1901 MCGEE STREET KANSAS CITY MO 64108
Business Address
Kunin Jeffrey (Reporting) CIK: 0001738782 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33678 | Film No.: 211422276